Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review

While the advent of immune-checkpoint inhibitors has revolutionized cancer therapy, immune-related adverse effects (irAEs) have also been on the rise. Cutaneous toxicities are among the most common irAEs, especially in the context of programmed cell death protein-1 (PD-1) inhibitors like pembrolizum...

Descripción completa

Detalles Bibliográficos
Autores principales: Madan, Vrinda, Marchitto, Mark C., Sunshine, Joel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443361/
https://www.ncbi.nlm.nih.gov/pubmed/37606485
http://dx.doi.org/10.3390/dermatopathology10030033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443361/
https://www.ncbi.nlm.nih.gov/pubmed/37606485
http://dx.doi.org/10.3390/dermatopathology10030033

Ejemplares similares